{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:49:42Z","timestamp":1792802982552,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Non-typhoidal\n                      <jats:italic>Salmonella<\/jats:italic>\n                      (NTS) infection is thought to be more severe in cancer patients, but this has not been studied since the development of new cancer therapies, increasing antibiotic resistance and the introduction of new antibiotics. We sought to describe the demographic characteristics, microbiological findings, clinical manifestations, and outcomes of NTS infections in cancer patients at our institution.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reviewed microbiology laboratory records and identified patients who had cancer and from whom NTS organisms were recovered between January 1, 2000 and December 31, 2013, at a comprehensive cancer center in Houston, Texas. Descriptive statistics were used to summarize patient characteristics, clinical presentation and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 110 isolates from 82 patients with 88 episodes of NTS infection (including five relapses [6%] in four patients, and two consecutive episodes in one patient). Fifty-five patients (67%) had hematologic malignancies. Most NTS isolates were susceptible to the commonly prescribed antimicrobials. Sixty-nine percent of patients had sepsis and one-third had severe sepsis or septic shock. Gastroenteritis, bacteremia, or both were present in 69% of patients, and the rest had focal infection. Mortality at 30 days was low (8%). Relapses occurred only in patients receiving\u2009\u2264\u200910 days of antibiotic therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>NTS affects predominantly patients with hematologic malignancies, followed by gastrointestinal and genitourinary cancers. Invasive disease, sepsis, and septic shock are common presentations among admitted patients. Antimicrobial prophylaxis may not prevent NTS infection. Thirty-day mortality and attributable mortality rates were low in our series compared to older case series. Early appropriate antibiotic therapy may have had a role in decreasing mortality. Relapses occurred in patients receiving\u2009\u2264\u200910 days of therapy, suggesting the need for longer duration of antibiotic therapy in cancer patients with uncomplicated NTS infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-021-06710-7","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T08:04:50Z","timestamp":1632902690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical presentation and outcomes of non-typhoidal Salmonella infections in patients with cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Nobuyoshi","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel D.","family":"Szvalb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier A.","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Tarrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7028-4860","authenticated-orcid":false,"given":"Victor E.","family":"Mulanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"issue":"4","key":"6710_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1017\/S0950268818000195","volume":"146","author":"MR Powell","year":"2018","unstructured":"Powell MR, Crim SM, Hoekstra RM, Williams MS, Gu W. Temporal patterns in principal Salmonella serotypes in the USA; 1996\u20132014. Epidemiol Infect. 2018;146(4):437\u201341.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"6710_CR2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1086\/313990","volume":"31","author":"E Delarocque-Astagneau","year":"2000","unstructured":"Delarocque-Astagneau E, Bouillant C, Vaillant V, Bouvet P, Grimont PA, Desenclos JC. Risk factors for the occurrence of sporadic Salmonella enterica serotype typhimurium infections in children in France: a national case-control study. Clin Infect Dis. 2000;31(2):488\u201392.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"6710_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jinf.2008.03.012","volume":"56","author":"MA Gordon","year":"2008","unstructured":"Gordon MA. Salmonella infections in immunocompromised adults. J Infect. 2008;56(6):413\u201322.","journal-title":"J Infect"},{"issue":"9","key":"6710_CR4","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","volume":"102","author":"J Leonard","year":"2007","unstructured":"Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol. 2007;102(9):2047\u201356 (quiz 2057).","journal-title":"Am J Gastroenterol"},{"key":"6710_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1476-0711-8-15","volume":"8","author":"A Dhanoa","year":"2009","unstructured":"Dhanoa A, Fatt QK. Non-typhoidal Salmonella bacteraemia: epidemiology, clinical characteristics and its\u2019 association with severe immunosuppression. Ann Clin Microbiol Antimicrob. 2009;8:15.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"19","key":"6710_CR6","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJM196705112761901","volume":"276","author":"T Han","year":"1967","unstructured":"Han T, Sokal JE, Neter E. Salmonellosis in disseminated malignant diseases. a seven\u2013 year review (1959\u20131965). N Engl J Med. 1967;276(19):1045\u201352.","journal-title":"N Engl J Med"},{"issue":"4","key":"6710_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/oxfordjournals.aje.a121072","volume":"90","author":"CE Cherubin","year":"1969","unstructured":"Cherubin CE, Fodor T, Denmark LI, Master CS, Fuerst HT, Winter JW. Symptoms, septicemia and death in salmonellosis. Am J Epidemiol. 1969;90(4):285\u201391.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"6710_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jmii.2011.12.015","volume":"45","author":"CW Li","year":"2012","unstructured":"Li CW, Chen PL, Lee NY, Lee HC, Chang CM, Lee CC, Ko WC. Non-typhoidal Salmonella bacteremia among adults: an adverse prognosis in patients with malignancy. J Microbiol Immunol Infect. 2012;45(5):343\u20139.","journal-title":"J Microbiol Immunol Infect"},{"issue":"8","key":"6710_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S1726-4901(09)70397-1","volume":"72","author":"YF Yen","year":"2009","unstructured":"Yen YF, Wang FD, Chiou CS, Chen YY, Lin ML, Chen TL, Liu CY. Prognostic factors and clinical features of non-typhoid Salmonella bacteremia in adults. J Chin Med Assoc. 2009;72(8):408\u201313.","journal-title":"J Chin Med Assoc"},{"issue":"2","key":"6710_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/BF00572093","volume":"2","author":"LM Noriega","year":"1994","unstructured":"Noriega LM, Van der Auwera P, Daneau D, Meunier F, Aoun M. Salmonella infections in a cancer center. Support Care Cancer. 1994;2(2):116\u201322.","journal-title":"Support Care Cancer"},{"issue":"4","key":"6710_CR11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/archinte.1971.00310220054005","volume":"128","author":"MS Wolfe","year":"1971","unstructured":"Wolfe MS, Louria DB, Armstrong D, Blevins A. Salmonellosis in patients with neoplastic disease. A review of 100 episodes at Memorial Cancer Center over a 13-year period. Arch Intern Med. 1971;128(4):546\u201354.","journal-title":"Arch Intern Med"},{"issue":"2","key":"6710_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/qjmed\/89.2.123","volume":"89","author":"JM Ramos","year":"1996","unstructured":"Ramos JM, Garcia-Corbeira P, Aguado JM, Ales JM, Soriano F. Classifying extraintestinal non-typhoid Salmonella infections. QJM. 1996;89(2):123\u20136.","journal-title":"QJM"},{"issue":"6","key":"6710_CR13","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992;101(6):1644\u201355.","journal-title":"Chest."},{"issue":"4","key":"6710_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1086\/515186","volume":"28","author":"Z Shimoni","year":"1999","unstructured":"Shimoni Z, Pitlik S, Leibovici L, Samra Z, Konigsberger H, Drucker M, Agmon V, Ashkenazi S, Weinberger M. Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin Infect Dis. 1999;28(4):822\u20137.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"6710_CR15","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10096-004-1206-5","volume":"23","author":"J Delaloye","year":"2004","unstructured":"Delaloye J, Merlani G, Petignat C, Wenger A, Zaman K, Monnerat C, Matzinger O, Beck Popovic M, Vuichard P, Ketterer N, et al. Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization? Eur J Clin Microbiol Infect Dis. 2004;23(10):751\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"6710_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1086\/318457","volume":"32","author":"EL Hohmann","year":"2001","unstructured":"Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis. 2001;32(2):263\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"6710_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"6710_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00277-008-0662-x","volume":"88","author":"KO Gradel","year":"2009","unstructured":"Gradel KO, Norgaard M, Dethlefsen C, Schonheyder HC, Kristensen B, Ejlertsen T, Nielsen H. Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study. Ann Hematol. 2009;88(8):761\u20137.","journal-title":"Ann Hematol"},{"issue":"5","key":"6710_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/00005792-198709000-00003","volume":"66","author":"JI Cohen","year":"1987","unstructured":"Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of salmonella infections. Medicine. 1987;66(5):349\u201388.","journal-title":"Medicine"},{"issue":"3","key":"6710_CR20","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1128\/AAC.01333-10","volume":"55","author":"JA Crump","year":"2011","unstructured":"Crump JA, Medalla FM, Joyce KW, Krueger AL, Hoekstra RM, Whichard JM, Barzilay EJ, Emerging Infections Program NWG. Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007. Antimicrob Agents Chemother. 2011;55(3):1148\u201354.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"6710_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1086\/427263","volume":"191","author":"JK Varma","year":"2005","unstructured":"Varma JK, Molbak K, Barrett TJ, Beebe JL, Jones TF, Rabatsky-Ehr T, Smith KE, Vugia DJ, Chang HG, Angulo FJ. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis. 2005;191(4):554\u201361.","journal-title":"J Infect Dis"},{"issue":"2","key":"6710_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1089\/fpd.2016.2180","volume":"14","author":"M Iwamoto","year":"2017","unstructured":"Iwamoto M, Reynolds J, Karp BE, Tate H, Fedorka-Cray PJ, Plumblee JR, Hoekstra RM, Whichard JM, Mahon BE. Ceftriaxone-resistant nontyphoidal Salmonella from humans, retail meats, and food animals in the United States, 1996\u20132013. Foodborne Pathog Dis. 2017;14(2):74\u201383.","journal-title":"Foodborne Pathog Dis"},{"issue":"3","key":"6710_CR23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","volume":"45","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486\u2013552.","journal-title":"Crit Care Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06710-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06710-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06710-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T08:05:09Z","timestamp":1632902709000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06710-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6710"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06710-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"13 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted at The University of Texas MD Anderson Cancer Center in Houston, Texas, after approval by its Institutional Review Board. Informed consent waiver was granted because of the retrospective, non-interventional nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1021"}}